Copy For Citation
KOYUNCU A., Celebi F., Ertekin E., Kok B. E., Tukel R.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, vol.7, no.11, pp.241-247, 2017 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
7
Issue:
11
-
Publication Date:
2017
-
Doi Number:
10.1177/2045125317714193
-
Journal Name:
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
-
Page Numbers:
pp.241-247
-
Keywords:
attention-deficit/hyperactivity disorder, comorbidity, extended-release methylphenidate, social anxiety disorder, treatment, DEFICIT HYPERACTIVITY DISORDER, AGE-DEPENDENT DECLINE, PSYCHIATRIC COMORBIDITY, ATOMOXETINE TREATMENT, CONTROLLED-TRIAL, ADHD, CHILDREN, PREVALENCE, PHOBIA, PREDICTORS
-
Istanbul University Affiliated:
Yes
Abstract
Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research.